抗药物中的联合结晶:通向更好的治疗结果的途径
Bhagyashree Patil1, Sanjay Surana2, Atul Shirkhedkar3
1Pharmaceutics, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, IND.
Cureus
|May 15, 2025
概括
药用共晶增强药物特性,如可溶性和生物可用性,而不会改变化学结构. 本次审查强调了它们在改善抗药物 (AED) 的潜力.
科学领域:
- 制药科学 制药科学
- 药物运输 药物运输 药物运输
- 固态化学 固态化学
背景情况:
- 药品共晶可以改善活性药品成分 (API) 的物理化学特性.
- 这对于生物制药分类系统 (BCS) 的II和IV类药物具有较差的水溶性和较低的生物可用性至关重要.
- 同结晶包括通过非共价相互作用将API与共同形成物结合到晶格中.
研究的目的:
- 审查药品共晶在提高药物性能方面的潜力.
- 专注于用于抗药物 (AED) 的共晶体的应用和开发.
- 探索共晶生成方法,评估技术和监管方面的考虑.
主要方法:
- 关于制药共晶研究的文献综述.
- 对API属性增强的联合结晶技术的分析.
- 检查在抗药物开发中的晶应用.
主要成果:
- 同结晶显著增强药物的特性,如稳定性,溶解性,溶解率和生物可用性.
- 晶技术提供了一种可行的策略,可以提高难溶性药物的治疗效果.
- 该审查表明,在开发先进的抗药物方面,可晶体具有巨大的潜力.
结论:
- 同结晶是一种强大的技术,可以提高药物性能,克服生物可用性挑战.
- 药用共晶体代表了一种有前途的方法,用于提高抗药物的疗效和输送.
- 在共晶设计和调节方面进行进一步的研究和开发对于临床转化至关重要.
相关概念视频
Antiepileptic Drugs: Potassium Channel Activators
137
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
137
Antiepileptic Drugs: Calcium Channel Blockers
270
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
270
Antiepileptic Drugs: Sodium Channel Blockers
305
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
305
Antiepileptic Drugs: GABAergic Pathway Potentiators
295
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
295
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
265
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
265
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
200
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
200


